Almost all doctors who are treating the coronavirus infected patients and received mild forms of Covid-19 have developed antibodies to prevent reinfection, as per the study conducted on hospital staff in northeastern France, as per the Bloomberg report.
Out of 160 volunteers for the study, 159 successfully developed antibodies within a fortnight after the start of infection, Institut Pasteur and university hospitals in Strasbourg said in an early version of their findings released before peer review.
Almost all of the staff tested had antibodies that were capable of neutralizing the virus within 41 days of developing symptoms.
The findings revealed that people who are mildly infected with the virus are capable of protecting them against reinfection.
The World Health Organisation (WHO) had said on April 24 that there was no evidence yet that people who have recovered and have antibodies are protected from a second infection.
"This finding supports the use of serologic testing for the diagnosis of individuals who have recovered from SARS-CoV-2 infection," Institut Pasteur's Arnaud Fontanet and colleagues wrote in the paper.
More of the hospital staff developed neutralizing antibodies over time, with only 79 per cent of the volunteers exhibiting them within 20 days, compared with 98 per cent detected after 41 days. All of them had their infections confirmed by tests at the time they were ill, Bloomberg report added.
Thank you for being a loyal user of Portfolio.
Portfolio will be a paid section hereon.
Please Subscribe to get access to one of our early bird packs.
Or click on Free Trial to get 14 days free trial.
What You'll Get
-
Web + Mobile
Access exclusive content of the Hindu Businessline across desktops, tablet and mobile device.
-
Exclusive Portfolio and Investment Advice, Banking, Lifestyle and Specials
Get diverse set of perspectives from our trusted experts on Portfolio, Banking, Economy, Environment and others.
-
Ad free experience
Experience cleaner site with zero ads and faster load times.
-
Personalised dashboard
Customize your preference and get a personalized recommendation of stories based on your interest.
Published on
May 27, 2020
A letter from the Editor
Dear Readers,
The coronavirus crisis has changed the world completely in the last few months. All of us have been locked into our homes, economic activity has come to a near standstill. Everyone has been impacted.
Including your favourite business and financial newspaper. Our printing and distribution chains have been severely disrupted across the country, leaving readers without access to newspapers. Newspaper delivery agents have also been unable to service their customers because of multiple restrictions.
In these difficult times, we, at BusinessLine have been working continuously every day so that you are informed about all the developments – whether on the pandemic, on policy responses, or the impact on the world of business and finance. Our team has been working round the clock to keep track of developments so that you – the reader – gets accurate information and actionable insights so that you can protect your jobs, businesses, finances and investments.
We are trying our best to ensure the newspaper reaches your hands every day. We have also ensured that even if your paper is not delivered, you can access BusinessLine in the e-paper format – just as it appears in print. Our website and apps too, are updated every minute, so that you can access the information you want anywhere, anytime.
But all this comes at a heavy cost. As you are aware, the lockdowns have wiped out almost all our entire revenue stream. Sustaining our quality journalism has become extremely challenging. That we have managed so far is thanks to your support. I thank all our subscribers – print and digital – for your support.
I appeal to all or readers to help us navigate these challenging times and help sustain one of the truly independent and credible voices in the world of Indian journalism. Doing so is easy. You can help us enormously simply by subscribing to our digital or e-paper editions. We offer several affordable subscription plans for our website, which includes Portfolio, our investment advisory section that offers rich investment advice from our highly qualified, in-house Research Bureau, the only such team in the Indian newspaper industry.
A little help from you can make a huge difference to the cause of quality journalism!
Support Quality Journalism